Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers

Completed · Phase 4

Conditions studied: Transplant Rejection

In brief

The purpose of this study is to determine the effects of belatacept on the pharmacokinetics of caffeine, losartan, omeprazole, dextromethorphan and midazolam

Key facts

Study ID

NCT01766050

Run by

Bristol-Myers Squibb

People needed

45

Starts

2013-01-01

Expected to finish

2013-04-01

Last updated by the study team

2014-06-27

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI 18 to 30 kg/m2
• Men and women ages 18 to 45

You may not qualify if…

• Active tuberculosis
• Any recent infection requiring antibiotic treatment within 4 weeks of dosing
• Positive urine screen for drugs of abuse

Where it is running

• Healthcare Discoveries, Llc D/B/A Icon Development Solutions — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.